High impact
Molecular Testing of Tumor Tissue to Identify Targeted Therapies for Cancers 2.02.51
Excellus BlueCross BlueShield·Effective Feb 19, 2026
CPT 81120 is referenced in 1 tracked payer policy change from Excellus BlueCross BlueShield. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 81120 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.